EDITORS' CHOICE

BIO CEO hails congressional report on threat of China dominating biotech

A year after a congressional commission urged strategic action to prevent China from replacing America as the world leader in biotechnology, we still have much ...

March 30, 2026

SBIR reauthorization, a top BIO priority, is passed by Congress

March 18, 2026

BIO lauds passage of PPRV reauthorization and legislation on PBM reform

February 4, 2026

LATEST NEWS

BIO expert: Future of biotech depends on competing with China, updating FDA

BIO’s comments for USTR report highlight global threats to intellectual property

Biotech innovation makes inroads against bleeding disorders

BIO CEO hails congressional report on threat of China dominating biotech

HEALTH

Biotech innovation makes inroads against bleeding disorders

April 2, 2026

BIO CEO hails congressional report on threat of China dominating biotech

March 30, 2026

Poll: U.S. voters want PBM and insurance reform—and strong biotech

March 26, 2026

BIO Board member advises Congress on China’s clinical trial competition

March 23, 2026

BIG Summit themes: Resilient investment, MFN threat, patients in the center

March 16, 2026

BIG Summit panel breaks down risks and opportunities coming out of DC

March 13, 2026

The hidden layer of PBMs: What a recent investigation reveals

March 9, 2026

Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care

March 6, 2026

BIG Summit: Experts see signs of M&A momentum in 2026

March 5, 2026

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

BIO’s comments for USTR report highlight global threats to intellectual property

April 6, 2026

BIO CEO hails congressional report on threat of China dominating biotech

March 30, 2026

BIG Summit themes: Resilient investment, MFN threat, patients in the center

March 16, 2026

BIG Summit panel breaks down risks and opportunities coming out of DC

March 13, 2026

The hidden layer of PBMs: What a recent investigation reveals

March 9, 2026

Nearly half of Americans say insurers’ rules on access delayed, denied, or altered care

March 6, 2026

State Policy

BIO on the American Road in Puerto Rico: ‘Medicine Cabinet’ ready to reshore

March 16, 2026

Known as “America’s Medicine Cabinet,” Puerto Rico is working to maintain its leadership in U.S. biotech production by becoming a ...

Charlotte emerging as a global leader in health care innovation and med tech

December 10, 2025

BIO-CSBA report explains why and how states seek to attract biotech

December 2, 2025

BIO on the American Road: Indiana, a production powerhouse, is still expanding

November 17, 2025

BIO PACE 2025: Patients need to ensure state policies enable access to medicine

October 28, 2025

International

BIO expert: Future of biotech depends on competing with China, updating FDA

April 7, 2026

BIO’s comments for USTR report highlight global threats to intellectual property

April 6, 2026

BIG Summit: Seeking opportunities while navigating risks of global trade

March 3, 2026

BIO 2025: The world can’t wait – it needs to collaborate

June 23, 2025

BIO group to suggest global guidelines for regulating cell and gene therapies

May 29, 2025

BIO IP expert reviews the current policy landscape

April 26, 2025

Bio's View

BIO’s comments for USTR report highlight global threats to intellectual property

April 6, 2026

Strong intellectual property protections sustain biotechnology innovation by enabling the investment needed to develop new medical breakthroughs. In comments submitted ...